Psilocybin‐assisted psychotherapy for methamphetamine use disorder: A pilot open‐label safety and feasibility study
Psilocybin assisted psychotherapy for methamphetamine use disorder was feasible to implement in an outpatient setting and did not appear to generate safety concerns. A larger randomised controlled trial is required to confirm efficacy and safety.
Authors
- Nadine Ezard (ORCID: https://orcid.org/0000-0002-7495-8305)
- Paul Liknaitzky (ORCID: https://orcid.org/0000-0001-5690-2263)
- Gillinder Bedi (ORCID: https://orcid.org/0000-0002-6718-0099)
- Krista J. Siefried (ORCID: https://orcid.org/0000-0002-6534-3325)
- Elizabeth Knock
- Steven M. Albert (ORCID: https://orcid.org/0000-0001-6786-9956)
- Richard Osborne Day (ORCID: https://orcid.org/0000-0002-6045-6937)
- Jonathan Brett (ORCID: https://orcid.org/0000-0003-3065-7495)
- Margaret Ross
Institutions
- New South Wales Department of Health (AU)
- UNSW Sydney (AU)
- St Vincent's Hospital Melbourne (AU)
- Orygen Youth Health (AU)
- St Vincent's Clinic (AU)
- National Centre for Clinical Research on Emerging Drugs (AU)
- Monash University (AU)
Publication Details
- Journal
- Addiction
- Published
- 2025-09-20
- DOI
- https://doi.org/10.1111/add.70187
- Citations
- 1
- Primary Topic
- Psychedelics and Drug Studies
- Type
- article
- Field-Weighted Citation Impact
- 2.31
Funders
- St. Vincent's Clinic Foundation
- Usona Institute
- University of New South Wales
- Medical Research Council
- National Health and Medical Research Council